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Microphthalmia with limb anomalies (MLA) is a rare autosomal-recessive disorder, presenting with anophthalmia or microphthalmia
and hand and/or foot malformation. We mapped the MLA locus to 14q24 and successfully identified three homozygous (one nonsense
and two splice site) mutations in the SPARC (secreted protein acidic and rich in cysteine)-related modular calcium binding 1 (SMOC1) in
three families. Smoc1 is expressed in the developing optic stalk, ventral optic cup, and limbs of mouse embryos. Smoc1 null mice reca-
pitulatedMLA phenotypes, including aplasia or hypoplasia of optic nerves, hypoplastic fibula and bowed tibia, and syndactyly in limbs.
A thinned and irregular ganglion cell layer and atrophy of the anteroventral part of the retina were also observed. Soft tissue syndactyly,
resulting from inhibited apoptosis, was related to disturbed expression of genes involved in BMP signaling in the interdigital mesen-
chyme. Our findings indicate that SMOC1/Smoc1 is essential for ocular and limb development in both humans and mice.Introduction
Microphthalmia with limb anomalies (MLA [MIM
206920]), also known as Waardenburg anophthalmia syn-
drome or ophthalmoacromelic syndrome, is a rare auto-
somal-recessive disorder first described by Waardenburg.1
It is characterized by ocular anomalies ranging from mild
microphthalmia to true anophthalmia and by limb anom-
alies such as oligodactyly, syndactyly, and synostosis of the
4th and 5th metacarpals.2–4 The genetic cause for MLA has
remained unknown.
It is widely known that secreted signaling molecules
such as Sonic hedgehog (Shh), wingless-type MMTV inte-
gration site family (Wnt), transforming growth factor
b (Tgf-b), bone morphogenetic proteins (Bmps), and fibro-
blast growth factor (Fgf) are involved in the development
of many organs and tissues, including the eyes and
limbs.5,6 In particular, mutations in BMP4 (MIM 112262)
have resulted in anophthalmia with systemic manifesta-
tions, including polydactyly and/or syndactyly (also
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both the developing eye and limb.
SMOC1 (MIM 608488), which encodes SPARC (secreted
protein acidic and rich in cysteine)-related modular
calcium binding 1, is a member of the SPARC (also known
as BM-40) matricellular protein family that modulates
cell-matrix interaction by binding to many cell-surface
receptors, the extracellular matrix, growth factors, and
cytokines.8,9 SMOCs are extracellular glycoproteins with
five domains: an N-terminal follistatin-like (FS) domain,
two thyroglobulin-like (TY) domains, a domain unique
to SMOC, and an extracellular calcium-binding (EC)
domain.9 SMOC1 is widely expressed in various tissues
with localization to basement membranes.9,10 Although
the biological function of SMOC1 remains largely
unknown, it has been recently reported that Xenopus
smoc protein, the ortholog of human SMOC1, acts as
a BMP antagonist,11 suggesting that human SMOC1 can
also modulate BMP signaling.
Here, we demonstrate that SMOC1 mutations cause
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MLA phenotypes, indicating that SMOC1 plays essential
roles in both eye and limb development in humans and
mice.Subjects and Methods
Subjects
A total of four families with one or two cases of MLAwere analyzed
in this study, including three previously reported families (A, B,
and C).12,13 Family X from Turkey, which has been previously
described,14 was newly recruited to this study. Detailed clinical
information of all the patients is available in the literature,12,14
and phenotypes of patients with confirmedmutations are summa-
rized in Table S1 (available online). A total of five affected and 16
unaffected members from the four families were analyzed in the
linkage study. Genomic DNA was obtained from peripheral-blood
leukocytes with the use of QuickGene 610-L (Fujifilm, Tokyo,
Japan) after informed consent had been given. Experimental
protocols were approved by the institutional review board of Yoko-
hama City University School of Medicine.SNP Genotyping, and Fine Mapping with Short
Tandem Repeat Markers
Whole-genome SNP genotyping, with the use of GeneChip
Human Mapping 50K Array XbaI (Affymetrix, Santa Clara, CA),
and fine mapping of possible candidate regions, with the use of
additional microsatellite markers, were performed as previously
described.12,15 The list of primers used for fine mapping is
presented in Table S2.Linkage Analysis
Multipoint linkage analyses using aligned SNPs were performed
with ALLEGRO software.16 Two-point linkage analyses of candi-
date regions were performed with the LINKAGE package MLINK
(FASTLINK software, version 5.1). In each program, an auto-
somal-recessive model of inheritance with complete penetrance
and a disease-allele frequency of 0.001 were applied.Mutation Analysis of Candidate Genes
All coding exons and exon-intron boundaries of RAD51L1 (MIM
602948), ACTN1 (MIM 102575), ERH (MIM 601191), SRSF5
(MIM 600914), DCAF5 (MIM 603812), COX16, EXD2, GALNTL1,
SLC39A9, KIAA0247, MED6 (MIM 602984), TTC9 (MIM
610488), MAP3K9 (MIM 600136), and SMOC1 (transcript variant
1, GenBank accession number NM_001034852.1) were analyzed
in the probands of families A, C, and X. The transcript variant
2 of SMOC1 (GenBank accession number NM_022137.4) is 3 bp
shorter than the variant 1, leading to an in-frame amino acid
deletion at position 431. PCR was cycled 35 times at 94C for
30 s, at 60C for 30 s, and at 72C for 30–90 s in a total volume
of 20 ml containing 30 ng genomic DNA as a template, 0.5 mM
forward and reverse primers, 200 mM each deoxyribonucleotide
triphosphate (dNTP), 13 ExTaq buffer, and 0.25 U ExTaq (Takara).
All primers were designed with Primer3 software. Detailed infor-
mation of primers is available upon request. PCR products were
purified with ExoSAP (USB) and sequenced with BigDye Termi-
nator 3.1 (Applied Biosystems) on a 3100 Genetic Analyzer.
Sequences of patients were compared to reference genome
sequences in the UCSC Genome Browser (February 2009The Aassembly) with Seqscape software, version 2.1 (Applied Biosys-
tems).Animals
Smoc1 mutant mice, created with the use of the Sleeping Beauty
transposon system, have been previously described.17 Line
PV384 was provided by the RIKEN BioResource Center through
the National BioResource Project of MEXT, Japan. Three indepen-
dent mouse lines (no. 1 to no. 3), each with a single insertion in
intron 1 of Smoc1, were bred as heterozygotes. Lines 1 and 3
were backcrossed for at least four generations to a C57BL/6J back-
ground. Line 2 was maintained with a mixed background of
C57BL/6J and ICR. We mainly analyzed line 1, but we confirmed
similar phenotypes in lines 2 and 3. Animals were housed in accor-
dance with protocols approved by the Institutional Animal Care
and Use Committee at Yokohama City University, School of Medi-
cine. PCR genotyping of mice was performed with the use of
genomic DNA from yolk-sac, ear, or tail biopsies. The following
primers were used: PV384-WF, 50-AAAGGCTGGGAATTGTTTG
A-30; PV384-WR,50-TGCAGCTGAAACTGTCTCTCC-30; PV384-MF,
50-TGTCCTAACTGACTTGCCAAA-30. The PV384-WF/PV384-WR
primers amplified a 441 bp wild-type (WT) product, and the
PV384-MF/PV384-WRprimers amplified a 218 bpmutant product.Southern Hybridization
Genomic DNA was extracted from livers or tail biopsies of PV384
heterozygous (Smoc1Tp/þ) mice via standard protocols. The gene-
trap insertions were analyzed by Southern hybridization with
the use of 10 mg of SacI-, NdeI-, BglII-, and EcoR_-digested DNA.
The probe (451 bp), which hybridized to the internal ribosome
entry site (IRES) in the gene-trap vector, was synthesized with
the DIG PCR Probe Synthesis Kit (Roche) with the use of the
following primers: 50-CTAACGTTACTGGCCGAAGC-30 and 50-
CCCAGATCAGATCCCATACAA-30. Hybridization, washing, and
detection of probes were performed according to the manufac-
turer’s protocol. Images were captured with the FluorChem system
(Alpha Innotech).Cloning of Gene-Trap Insertion Sites
After identification of aberrant DNA fragments by Southern
hybridization, NdeI-, SacI-, and EcoR_-digested DNA from PV384
mice was fractionated by electrophoresis, and appropriately sized
fragments containingOl1 (other locus 1),Ol2, andOl3were isolated
with a QIAEXII Gel Extraction Kit (QIAGEN). The isolated DNA
was self-ligated by Ligation High ver.2 (Toyobo), precipitated
with ethanol, and dissolved in 20 ml EB buffer (QIAGEN). Inverse
PCR was performed in 25 ml reactions, containing 2 ml ligated
DNA, 1 3 PCR buffer for KOD FX, 0.4 mM each dNTP, 0.5 mM
each primer, and 0.5 U KOD FX DNA polymerase (Toyobo).
Primers common to Ol1, Ol2, and Ol3were as follows: Inv-F, 50- AT
CGCCAGTTCTGTATGAACGGTCTGGTCTT-30; Inv-R, 50-CCCTC
TTTACGTGCCAGCCATCTTAGAGATAC-30. Confirmatory PCR of
gene-trap insertion sites for Ol1, Ol2, and Ol3 loci was performed
with the use of the following primers: Ol1-F, 50-GAGTGGTATTCA
TTGGATTCTGCTGAT-30; Ol2-F, 50-AAATCCAGCTGGCCAACAGA
CTAAG-30; Ol3-F, 50-TTGCCGGGTAGACTCTATCAAGAACCA-30;
TBAL-R, 50-CTTGTGTCATGCACAAAGTAGATGTCC-30. Primer
sets of Ol1-F/TBAL-R, Ol2-F/TBAL-R, and Ol3-F/TBAL-R could
amplify 175 bp, 607 bp, and 767 bp products, respectively. These
PCR primer pairs were also used for genotyping of mice harboring
a single insertion at the Smoc1 locus.merican Journal of Human Genetics 88, 30–41, January 7, 2011 31
Confirmation of Promoter- and Poly(A)-Trapped
Transcripts
Whole embryos at embryonic day 10.5 (E10.5) and E11.5 were
stored in RNAlater solution (QIAGEN). Total RNA was extracted
from WT, Smoc1Tp/þ, and Smoc1Tp/Tp embryos with the use of
RNeasy Plus Mini (QIAGEN). One microgram total RNA was sub-
jected to reverse transcription with the use of a PrimeScript 1st
Strand Synthesis Kit with random hexamers (Takara). A control
reaction with no reverse transcriptase was included in each exper-
iment. PCR was performed in 20 ml reactions, containing 1 ml
cDNA, 1 3 PCR Buffer for KOD FX, 0.4 mM each dNTP, 0.3 mM
each primer, and 0.4 U KOD FX (Toyobo). Primers used are
listed below: Smoc1-F, 50-GTCCCCACCTCCCCAAGTGCTTTGA-30;
LacZ-R, 50-TGCCAAAAGACGGCAATATGGTGGAAA-30;GFP-F, 50-T
CACATGGTCCTGCTGGAGTTCGTGAC-30; Smoc1-R, 50-ACACT
TGCTCTGGCCAGCATCTTTGCAT-30. Primer sets of Smoc1-F/
Smoc1-R, Smoc1-F/LacZ-R, andGFP-F/Smoc1-R could amplify native
Smoc1 (366 bp), promoter-trapped transcripts (Tp-LacZ, 500 bp)
and poly(A)-trapped transcripts (Tp-GFP, 308 bp), respectively.
ThePCRconditionswere98Cfor10 s, 68Cfor1min, for30cycles.
Primers for ACTB18 were used as an internal control. PCR for ACTB
was cycled 20 times at 94C for 20 s, 60C for 20 s, and 72C for 30 s
in a total volume of 10 ml containing 0.5 ml cDNA, 0.4 mM each
primer, 0.2 mM each dNTP, 1 3 ExTaq buffer, and 0.5 U ExTaq HS
(Takara).All PCRproductswere electrophoresedon2%agarosegels.In Situ Hybridization
Embryos were collected between E9.5 and E13.5. Whole-mount
in situ hybridization was carried out as previously described.19,20
Two fragments of Smoc1 cDNA were obtained as probes by RT-
PCR,with the use of total RNA extracted from livers of E16.5mouse
embryos, and subcloned into pCR4-TOPO (Invitrogen). Primer
sequences were as follows: probe 1-F, 50-GTCTGCTCACGCCCC
ACT-30; probe 1-R, 50-CCTGAACCATGTCTGTGGTG-30; probe P-F,
50-CAGGAACAGGAAAGGGAAGA-30; probe P-R, 50-AAGGGAAA
ACCACACAGCAC-30. PCR products were 1023 bp and 1578 bp,
corresponding to nucleotide positions 275–1297 and 1849–3426
of the mouse Smoc1 cDNA (GenBank accession number
NM_001146217.1), respectively. The cDNA fragment amplified
with probe P-F and probe P-R primers was identical to the probe
used in a previous report.21 Digoxigenin-labeled sense and anti-
sense riboprobes were synthesized with the use of a digoxigenin
RNA labeling kit (Roche). These two different antisense probes
demonstrated identical staining patterns, and the control sense
probes showed no staining. The expression pattern was confirmed
with more than three embryos. In addition, the following probes
were used: Bmp2 (gift from Y. Takahashi),22 Sox9 (gift from
A. Yamada),22 Bmp7 (gift from E.J. Robertson), andMsx2 (gift from
Dr. R.E. Maxson, Jr). The numbers of embryos examined were as
follows (numerical quantity for WT, Smoc1Tp/þ, and Smoc1Tp/Tp,
respectively, shown in parentheses): Msx2 (2, 1, 3) at E11.5; Bmp2
(3, 0, 3), Bmp7 (3, 0, 3), Msx2 (3, 0, 3), and Sox9 (2, 1, 3) at E12.5;
Bmp2 (1, 2, 3), Bmp7 (2, 1, 3), Msx2 (1, 2, 3), and Sox9 (1, 3, 4) at
E13.5. Stained embryos were cleared in glycerol to enable images
to be produced with a VHX-1000 digital microscope (Keyence).Histology
Heads of embryos and newborns were fixed overnight in 4% para-
formaldehyde in PBS at 4C. These embryos were then washed in
PBS. Frozen samples were serially sectioned at 16 mm (E14.5) and
20 mm (P0). The numbers of eyes examined (WT, Smoc1Tp/þ,32 The American Journal of Human Genetics 88, 30–41, January 7, 20Smoc1Tp/Tp) were as follows: coronally sectioned at E14.5 (8, 10,
12), coronally sectioned at P0 (8, 10, 6), horizontally sectioned
at P0 (2, 2, 4). For evaluation of ventral atrophy of the retina,
only the coronally sectioned eyes were used. TB staining was per-
formed according to standard protocols. Forelimbs of mice were
fixed in 4% paraformaldehyde in PBS, decalcified in 10% EDTA,
and embedded in paraffin. Forelimbs were serially sectioned at
4 mm and stained with hematoxylin and eosin.
Evaluation of Optic Nerve Diameter
The palatine and orbital bones were carefully removed to expose
the optic chiasm and optic nerve. During the dissection process,
4% paraformaldehyde in PBS was frequently applied onto the
gaps between the bone and optic nerve. Xylene cyanol was applied
to enhance the outline of optic nerves at poastnatal day 0 (P0).
Photographs of optic nerves were taken with a VHX-1000 digital
microscope, and the diameter wasmeasured for right and left optic
nerves with the bundled software included with the VHX-1000
instrument.
Skeletal Staining
For skeletal preparations, mice were fixed in 99.5% ethanol after
removal of the skin and viscera. Cartilage tissues were stained
with 0.015% alcian blue and 20% acetic acid in 75% ethanol for
three days at 37C. After dehydration with 99.5% ethanol for three
days, boneswere stainedwith0.002%alizarin red in1%KOH.Then
skeletons were cleared in 1% KOH for several weeks. For P14 mice,
soft tissues were dissolved in 2% KOH before alizarin red staining.
Nile Blue Staining
For the study of apoptosis of hindlimbs at E13.5 and E14.5, Nile
blue (NB) staining was performed on the basis of a previously
described protocol,23 except that staining was performed at 37C
(not room temperature). Apoptosis was determined by NB-stained
(deceased) cells. After rinsing in Tyrode solution, hindlimbs of
control (WT and heterozygous littermates) and homozygous
mice were evaluated. Photographs of dorsal aspects were taken
with a VHX-1000 digital microscope. Experiments were repeated
three times, and reproducible representative results are presented.
Statistical Analysis
Statistical analyses were performed with the use of non-repeated-
measures ANOVA followed by Dunnett’s post hoc test. The results
are given asmean5 standard deviation, and the threshold p value
for statistical significance was 0.01.Results
Identification of Homozygous SMOC1 Mutations
We have previously mapped the MLA locus to a 422 kb
region at 10p11.23 by analyzing three families (one Japa-
nese family [A] and two Lebanese families [B and C]).
This region contained only one gene, MPP7, in which no
mutations were found.12 After a new Turkish family (X)
was added to the analysis, the MLA locus was again
searched by homozygosity mapping to the consanguin-
eous families (X, B, and C) and haplotype mapping to
family A for detection of compound-heterozygous muta-
tions; however, we could not detect any common regions11
among the four families. We then focused on identifying
common regions in any three of the four families to allow
for locus heterogeneity (Table S3).
A locus at 14q24.1-q24.2, which showed the highest
LOD score (3.936) among the candidate regions larger
than 2.0 Mb, was highlighted among families A, C, and
X. This locus was analyzed with the use of additional mi-
crosatellite markers, and a 3.0 Mb region containing
24 genes was identified (Figures 1A and 1B). A total of
14 genes were sequenced, and homozygous mutations
were found in SMOC1: c.718C>T (p.Gln240X) in family
A, c.664þ1G>A in family C, and c.378þ1G>A in family
X (Figures 1C and 1D). All of these homozygous mutations
were cosegregated with the disease phenotype, and the
parents of the individuals with these mutations were
heterozygous carriers (Figure 1C). We could not find any
mutations in SMOC1 in family B, in which MLA is
unlinked to the 14q24.1-q24.2 locus. Interestingly, in
family A haplotypes of paternal and maternal alleles,
each having the same mutation, are completely different
(data not shown), suggesting that the same mutation
may have occurred in separate events. The c.718C>T
mutation was not detected in 289 healthy Japanese
controls, including 100 Okinawa islanders. The other two
mutations were not detected in ethnically matched
controls (54 Lebanese and 99 Turkish subjects, respec-
tively), nor in 289 Japanese controls. The two splice-
donor-site mutations (c.664þ1G>A and c.378þ1G>A)
are predicted to abolish a donor site, as predicted by ESE-
finder, NetGene2, HSF2.4.1, SpliceView, and BDGP anal-
ysis (Table S4). Thus, the three mutations are likely to
lead to a loss of functional SMOC1.
Smoc1 Expression in the Developing Eye and Limb
in Mice
For the examination of Smoc1 expression in the developing
eye and limb, whole-mount in situ hybridization of mouse
embryos was performed. Smoc1 was expressed in the fore-
brain, midbrain, hindbrain, pharyngeal arch, somites,
and forelimb buds at E9.5 (Figure 2A). At E10.5, Smoc1
expression was observed in the optic stalk (Figure 2B),
and at E11.5, expression was localized to the closure site
of the optic cup (Figure 2C). Expression of Smoc1 in devel-
oping limbs between E10.5 and E11.5 was observed in
both dorsal and ventral regions, with a broader pattern of
expression in dorsal regions, but expression was not
detected in the most anterior, posterior, and distal parts
of limb buds (Figures 2D and 2E). Expression coinciding
with chondrogenic condensation was observed at E12.5
(Figure 2F), and expression then became restricted to
future synovial joint regions at E13.5 (Figure 2G). This
dynamic expression suggests that Smoc1 plays a critical
role in ocular and limb development.
Ocular and Limb Anomalies in Smoc1 Null Mice
To investigate the pathological basis of MLA due to the
loss of SMOC1 function, we obtained Smoc1 mutantThe Amice, PV384.17 PV384 mice possess gene-trap insertions
in the Smoc1 locus and in three other loci. After PV384
mice were bred with C57BL/6J or ICR mice, we obtained
three independent lines (no. 1 to no. 3), each with a sole
insertion in intron 1 of Smoc1 (Figure S1). We mainly
analyzed line 1, but we confirmed similar phenotypes in
lines 2 and 3. Heterozygous mutant mice (Smoc1Tp/þ)
were healthy and fertile. Homozygous mice (Smoc1TP/TP)
were null mutants, as they showed no native transcript
of Smoc1 (Figure S1E). Homozygous mice were viable at
P0; however, they did not survive beyond the first 3 wks
of life (Figure 3B). Their growth was retarded in compar-
ison to WT and heterozygous littermates at P0 and P14
(Figures 3A and 3C). Developmental defects in eyes and
optic nerves were evident at E14.5. Homozygous mice
had relatively small eyes, and histological examinations
revealed aplasia or hypoplasia of optic nerves (in 10 of
12 optic nerves), atrophy of the anteroventral part of the
retina (in 11 of 12 eyes), and extension of the retinal pig-
mented epithelium (RPE) to the optic nerve (in 10 of 12
eyes) (Figures 3D–3I). These abnormalities were also
observed at P0 (aplasia or hypoplasia of optic nerves [in
7 of 10 optic nerves], retinal atrophy [in 6 of 6 eyes],
and RPE extension [in 3 of 6 eyes with identifiable optic
nerves]) (Figures 3J–3M). WT or heterozygous littermates
did not show any such abnormalities, except that a few
eyes of heterozygous mice showed extension of the RPE
at E14.5, but not at P0 (in 2 of 10 and 0 of 12 eyes, respec-
tively). Toluidine blue (TB) staining showed ganglion cell
layers that were thinned and irregular to varying degrees
in homozygous mice, suggesting a reduced number of
retinal ganglion cells (Figures 3J–3K0). Thus, Smoc1 is
required for axon sprouting, elongation, or maintenance
of retinal ganglion cells.24 Hypoplasia of optic nerves
was further quantitatively confirmed by macroscopic
examination: the average diameter of optic nerves of
homozygous mice was significantly smaller than that of
WT and heterozygous littermates at P0 and P14 (Figures
3L–3Q). These data clearly demonstrate that loss of
Smoc1 in mice affects development of the body, retina,
and optic nerves, in a manner similar to that seen in
MLA patients.3,4
Newborn homozygous mice could be readily identified
by their hindlimb syndactyly and pes valgus, whereas no
abnormalities were observed in WT and heterozygous
pups (Figure 4 and Table 1). Interestingly, the severity of
syndactyly varied between mouse lines: line 1 exclusively
showed soft tissue syndactyly, whereas line 2 frequently
showed four digits (Figures 4F and 4J). Skeletal prepara-
tions with alcian blue and alizarin red revealed that the
foot with four digits had four phalanx and five metatarsals
with fusion to each other (Figure 4K). Thus the Smoc1 null
mutation resulted in a spectrum of phenotypes, from soft
tissue syndactyly to four fused digits, probably due to
different genetic backgrounds. Bowed tibiae and hypo-
plastic fibulae were also consistently observed in homozy-
gous mice (Figures 4H and 4L). The articulation betweenmerican Journal of Human Genetics 88, 30–41, January 7, 2011 33
Figure 1. Genetic Analysis of Three Families with Members Affected by Microphthalmia with Limb Anomalies
(A) Pedigrees of the three families.
(B) Linkage analysis with SNPs and microsatellite markers on chromosome 14. From left to right: chromosome ideogram, genetic
markers, linked regions of the three families, and genes mapped to the shortest overlapping linked region (between AFM114YH10
and Ch14-STS6 [UCSC coordinates, Feb. 2009: chromosome 14: 68,388,190–71,347,908 bp]).
(C) Sequences of mutations identified in each family. Affected patients in family A have a homozygous nonsense mutation (c.718C>T).
Patients in families C and X have distinct homozygous splice-donor site mutations (c.664þ1G>A and c.378þ1G>A, respectively). For all
mutations, parents of affected patients are heterozygous carriers, without exception. Sequences of the exon and intron are presented in
upper and lower cases, respectively.
(D) At the top is a depiction of a schematic representation of SMOC1 consisting of 12 exons (UTR and coding exons are indicated by open
and filled rectangles, respectively). The locations of three mutations are indicated by red dots. At the bottom, the functional domains of
SMOC1 are depicted. Abbreviations are as follows: FS, the follistatin-like domain; TY, the thyroglobulin-like domain; SMOC, the domain
unique to SMOC; and EC, the extracellular calcium-binding domain.
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Figure 2. Smoc1 Expression in Mouse Embryos
Lateral views of embryos (A–C) and a ventral view of the left part of the head (B0, lateral view is shown at the top).
(A) At E9.5, Smoc1 was expressed in the forebrain, midbrain, hindbrain, pharyngeal arch, somites, and forelimb buds (magenta arrow-
head), but not in the optic vesicle (Ov, blue arrow).
(B and B0) Expression in the optic stalk became evident at E10.5 (magenta asterisks), but was not evident in the optic cup (Oc, blue arrow).
(C) Expression was restricted to the closure site of the optic cup (dashed circle) at E11.5.
(D–G) Dorsal and (D0–G0) posterior view of the right hindlimbs (dorsal view is shown at the top in D0–G0). The anterior side is indicated by
an A. (D and D0) At E10.5, Smoc1was more widely expressed in the dorsal part of the limb bud than in the ventral part. Smoc1 expression
is undetected in the most anterior, posterior, and distal parts of the limb bud. (E and E0) At E11.5, ventral expression was broader than
that in the previous stage. (F and F0) At E12.5, expressionwas detected in areas consistent with chondrogenic condensation. (G andG0) At
E13.5, Smoc1 expression became restricted to future joint regions. Scale bar represents 500 mm.tibia/fibula and calcanea of homozygous mice appeared
malpositioned (Figures 4G and 4K), which might
contribute to pes valgus. At P14, soft tissue syndactyly
was also evident in most forelimbs of homozygous
mice (Figures 4M–4O). Moreover, hindlimbs of homozy-
gous mice showed synostosis between the 4th and 5th
metatarsals (Figure 4T), which is observed in both the
hands and the feet of MLA patients. Thus, many limb
anomalies of MLA patients were recapitulated in Smoc1
null mice (Table S1).
Reduced Interdigital Apoptosis and Disturbed BMP
Signaling
Among the various abnormalities caused by loss of Smoc1
function, we focused on soft tissue syndactyly, which
was commonly observed in both fore- and hindlimbs of
null mutants. It is possible that the syndactyly is caused
by failed apoptotic regression of the interdigital mesen-
chyme. To examine this hypothesis, hindlimbs were
stained with NB sulfate at E13.5 and E14.5, the timeThe Awhen interdigital apoptosis is most evident. In control
embryos (WT and heterozygous littermates), NB-stained
apoptotic cells were identified in the interdigital mesen-
chyme, where regression of the interdigital webbing occurs
in the distal region (Figures 5A and 5C). By contrast, the
number of apoptotic cells in the mesenchyme between
digits 2 and 3 and digits 3 and 4 was dramatically reduced
in homozygous mice at E13.5 and E14.5, along with
persistent webbing in the distal region (Figures 5B and
5D, magenta asterisk). BMP signaling is involved in
apoptosis of the interdigital mesenchyme.25,26 Bmp2,
Bmp7, and Msx2, a direct target of BMP signaling, were
strongly expressed in the interdigital mesenchyme of
control hindlimbs at both E12.5 and E13.5. However, the
expression of these three genes was profoundly reduced
and perturbed in hindlimbs of homozygous mice (Figures
5E–5J). These data suggest that inhibition of apoptosis is
spatiotemporally correlated to reduced and/or disturbed
expression of genes involved in BMP signaling in the inter-
digital mesenchyme.merican Journal of Human Genetics 88, 30–41, January 7, 2011 35
Figure 3. Growth and Ocular Phenotypes of Smoc1 Null Mice
(A) Representative Smoc1Tp/Tp mouse, showing a small body in comparison to Smoc1Tp/þ and WT littermates.
(B) Genotypes of living pups during the first 3 wk of life.
(C) Body weight of pups of each genotype at P0 (left panel) and P14 (right panel).
(D and E) Relatively small eyes were evident in Smoc1Tp/Tp mice in comparison to WT mice.
(F–K0) Coronal sections of eyes at E14.5 (F–I) and P0 (J–K0) with TB staining (H, I, and J–K0). (F-I) Atrophy of the anteroventral part of the
retina (G, magenta arrowheads, dorsal view shown at the top), hypoplastic optic nerve, and extension of the RPE to the optic nerve
(I, magenta arrow) in Smoc1Tp/Tpmice at E14.5. (J and K) Hypoplastic optic nerve and RPE extension in Smoc1Tp/Tpmice at P0 (K, magenta
arrow). Note that sections in which optic nerves appeared most thick are presented in (H–K). (J0–K0) In higher-magnification views of
(J and K), a thinned and irregular ganglion cell layer (white brackets) was observed in Smoc1Tp/Tp mice. Abbreviations are as follows:
le, lens; re, retina; rpe, retinal pigmented epithelium.
(L–P) Ventral views of the brain showing optic nerves at P0 (L andM) and P14 (N–P), showing various degrees of optic nerve hypoplasia.
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Discussion
In a previous report, we performed parametric linkage
analysis with three families (families A, B, and C) and
found 16 loci showing a LOD score (q ¼ 0.000) higher
than 3.0. Additional microsatellite markers highlighted
only one locus, 10p11.23.12 However, no mutations were
found in the candidate gene MPP7.12 By recruiting a new
family (family X) to this study, we successfully found
homozygous mutations in SMOC1 in families A, C, and
X. In family B, no SMOC1 mutations were found, indi-
cating the genetic heterogeneity in MLA. Patients with
SMOC1 mutations and Smoc1 null mice showed similar
limb anomalies, such as oligodactyly, syndactyly, synos-
tosis of 4th and 5th metacarpals, hypoplasia of fibula, and
bowed tibia. Oligodactyly, syndactyly, and synostosis of
4th and 5th metacarpals are common in MLA patients.2–4
However, hypoplastic fibula and bowed tibia are less
common in patients with MLA, as four out of 34 MLA
patients showed these anomalies in the previous report.3
Although one patient with a SMOC1mutation from family
C did not show bowed tibia and hypoplastic fibula, these
anomalies could be features specific to SMOC1 mutations.
Further SMOC1 analysis of other MLA patients should
delineate the phenotypic consequences caused by
SMOC1 mutations.
Accumulating evidence suggests that BMP signaling
plays crucial roles in early eye vesicle and limb patterning,
skeletal formation, and apoptosis of the interdigital mesen-
chyme,25–29 and mutations involving BMP signaling cause
human malformations including ocular, limb, and skeletal
anomalies.7,30–33 Here, we present genetic evidence that
SMOC1 is essential for ocular and limb development in hu-
mans and mice. Furthermore, Xenopus smoc can inhibit
BMP signaling,11 suggesting that SMOC1/Smoc1 can also
modulate BMP signaling in humans and mice. Indeed,
we observed reduced and/or disturbed expression of genes
involved in BMP signaling in the interdigital mesenchyme
in Smoc1 null mice, and limb and ocular abnormalities
associated with loss of Smoc1 function are consistent
with phenotypic consequences of disturbed BMP
signaling. Conditional inactivation of Bmp2 in the limb
showed 3/4 syndactyly, and a similar deficiency of both
Bmp2 and Bmp7 resulted in malformed fibulae in mice.25
Moreover, mice deficient in Fmn1, a repressor of BMP
signaling, showed four digits, fused metatarsal bones,
and an absence of fibulae in the hindlimbs,34 suggesting
the importance of altered BMP signaling in these features.
Concerning ocular phenotypes, haploinsufficiency of
mouse Bmp4 resulted in a decreased number of ganglion
layer cells and absence of the optic nerve similar to
Smoc1 null mice,35 indicating that altered BMP signaling(Q) Optic nerve diameter. Optic nerves were significantly hypoplastic
The numbers of pups (B and C) or eyes (Q) corresponding to each gen
ation: *p < 0.01, compared with WT. **p < 0.01, compared with WT
(F–I), 500 mm (J and K), and 100 mm (J0 and K0).
The Ais also involved in the ocular phenotype. Interestingly,
knockdown experiments of smoc by antisense morpholino
in Xenopus showed absence or severe deformity of the eye
and other anterior structures, which were accompanied by
aberrant expression of otx2, tbx2 in the eye field.11 Muta-
tions of OTX2 (MIM 600037) cause micropthalmia, syn-
dromic 5 (MCOPS5 [MIM 610125]) in humans.36 More-
over, targeted disruption of Tbx2 resulted in a marked
reduction in the size of the optic cup and a failure of optic
nerve formation in mice.37 Thus, it is possible that loss of
SMOC1 function could alter the expression of OTX2 and
TBX2 (MIM 600747) by disturbing BMP signaling in
human developing eyes.
It is unknown how the loss of functional SMOC1, a BMP
antagonist, leads to reduced expression of genes involved
in BMP signaling in the interdigital mesenchyme in
Smoc1 null mice. In the case of Fmn1-deficient mice, the
loss of the repressor of BMP signaling resulted in downre-
gulation of Fgf4 and Shh and in upregulation of Gremlin
expression at E10.5, and absence of apoptosis of the inter-
digital mesenchyme between the two middle digits at
E13.5.34 Thus, there is a possibility that loss of SMOC1
could cause the imbalance among BMP, SHH, and FGF
signaling, which would subsequently lead to reduced
and/or disturbed expression of genes involved in BMP
signaling in the interdigital mesenchyme. In fact, we
observed reduced expression of Msx2 in the progressive
zone of hindlimbs at E11.5 (Figure S2). Moreover, expres-
sion of Sox9, the initial cartilage condensation marker,
showed abnormal limb patterning, suggesting that
SMOC1 may affect BMP signaling even at early stages of
limb development (Figure S3). Further examinations are
required for understanding spatial and temporal actions
of SMOC1/Smoc1 protein during limb development.
In conclusion, our data demonstrate that SMOC1/Smoc1
is an essential player in both ocular and limb development
in humans andmice and give further support to the crucial
roles of BMP signaling in these systems.Supplemental Data
Supplemental Data include three figures and four tables and can
be found with this article online at http://www.cell.com/AJHG/.Acknowledgments
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Figure 4. Limb Phenotypes of Smoc1 Null Mice
Limbs of WT (A–D, M, and P) and Smoc1Tp/Tp mice (E–L, N–O0, and Q–T) at P0 (A–L) and P14 (M–T). Digit identities are indicated by the
numbers 1 (thumb, anterior) and 5 (little finger, posterior). Skeletal staining with alcian blue and alizarin red is presented (C, D, G, H, K,
L, S, and T). Smoc1Tp/Tpmice showed pes valgus (E and I), soft tissue syndactyly (F and G), and four digits withmetatarsal fusion (J and K).
Malposition of the articulation between the tibia/fibula and the calcanea (G and K, magenta arrowheads), bowed tibia (magenta arrows),
and hypoplastic fibula (arrowheads) of Smoc1Tp/Tpmice (H and L) were observed. 2/3 soft tissue syndactyly (N) and 2/3 webbing (O) were
evident in forelimbs of Smoc1Tp/Tp mice. (O0) A transverse section taken at the level indicated by the dashed line in (O) showed 2/3
webbing. 2/3 syndactyly (Q), 2/3/4 syndactyly (R), synostosis between the 2nd and 3rd proximal phalanx and metatarsals (S), and synos-
tosis between the 4th and 5th metatarsals (T, arrow), observed in the hindlimbs of Smoc1Tp/Tp mice. Scale bars represent 1 mm (A–O and
P–T) or 500 mm (O0).
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Table 1. Limb Abnormalities in Smoc1Tp/Tp Mutants
Genotype
Talipes Valgus
(No. of Affected/
Total No. of Pups)
Forelimb
Abnormalities
(No. of Limbs)
Hindlimb Syndactyly (No. of Limbs)
Other External
Abnormalities
(No. of Pups)
4th and 5th Metatarsal
Fusion (No. of
Affected/Total
No. of Limbs)None 2/3a 3/4b 2/3/4c 4 Digits
Postnatal Day 0
Smoc1Tp/þ
(line 1, C57BL/6J)
0/42 0 84 0 0 0 0
Smoc1Tp/þ
(line 2, ICR mixed)
0/38 0 76 0 0 0 0
Smoc1Tp/Tp
(line 1, C57BL/6J)
10/10 0 3 0 3 12 2
Smoc1Tp/Tp
(line 2, ICR mixed)
13/17 1d 1 1 9 4 19 cleft palate (3)
Postnatal Day 14
Smoc1Tp/þ
(line 1, C57BL/6J)
0/70 0 140 0 0 0 0
Smoc1Tp/Tp
(line 1, C57BL/6J)
11/11 18e 2 7 3 8 2 hypoplastic
thumbs (5)
9/10f
a Syndactyly between the 2nd and 3rd digits.
b Syndactyly between the 3rd and 4th digits.
c Syndactyly between the 2nd, 3rd, and 4th digits.
d 2/3 soft tissue syndactyly.
e Eleven limbs showed 2/3 webbing, four limbs showed 2/3 soft tissue syndactyly, and one limb showed 3/4 syndactyly.
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